Versartis, Inc. (NASDAQ:VSAR) - Hot Stock That Must Be in Your Portfolio

Adjust Comment Print

Baker Bros Advsrs Limited Partnership invested in 1.66M shares. The stock rose 0.19% or $0.11 reaching $57.29. The company had a trading volume of 308,060 shares. The stock of Versartis Inc (NASDAQ:VSAR) earned "Underperform" rating by Credit Suisse on Thursday, December 17. Perceptive Advisors Llc bought 125,000 shares as the company's stock declined 2.45% while stock markets rallied.

Versartis has a 52 week low of $2.90 and a 52 week high of $24.00 The company's market cap is now $0. About 484,998 shares traded.

Analysts are weighing in on biotech stocks Versartis Inc (NASDAQ:VSAR) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as well as luxury retailer Tiffany & Co. It has outperformed by 86.48% the S&P500.

SELL rating has been given by 0 analyst (s) and 2 analyst (s) given BUY rating to the stock. The rating was upgraded by Citigroup to "Buy" on Thursday, June 9. The firm has "Buy" rating given on Wednesday, June 8 by Pivotal Research. The firm has "Hold" rating by BB&T Capital given on Wednesday, January 27. The firm has "Mkt Perform" rating given on Friday, December 16 by FBR Capital. (NYSE:GCO) earned "Neutral" rating by Buckingham Research on Friday, September 1.

Analysts await Versartis Inc (NASDAQ:VSAR) to report earnings on November, 2. Equities analysts predict that Versartis will post ($3.54) earnings per share for the current year. Next quarter's EPS is expected be $-0.86 with next year's EPS projected to be $-3.09. Versartis Inc (NASDAQ:VSAR) has risen 103.18% since September 22, 2016 and is uptrending. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the company. Therefore 58% are positive. Versartis Inc had 17 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Versartis Inc (NASDAQ:VSAR) has "Buy" rating given on Friday, September 8 by Piper Jaffray.

China's cenbank tells banks to stop doing business with N.Korea
The foreign minister made headlines Wednesday after he likened U.S. Chinese banks received the document on Monday, the sources said. President Donald Trump to a dog.


08/13/2015 - Morgan Stanley began new coverage on Versartis, Inc. giving the company a "equal weight" rating. The company was maintained on Friday, May 26 by Canaccord Genuity. As per Thursday, August 20, the company rating was initiated by Credit Suisse.

03/09/2017 - Barclays began new coverage on Versartis, Inc. giving the company a "overweight" rating. On September 22 the stock rating was downgraded to "Neutral" from "Overweight" in a statement from PiperJaffray.

Investors sentiment increased to 2.27 in Q4 2016. Its up 0.17, from 2.1 in 2016Q3.

Investors are a little more bearish on Versartis, Inc. lately considering the uptick in short interest. 8 funds opened positions while 42 raised stakes. Commonwealth Of Pennsylvania Pub School Empls Retrmt System owns 38,462 shares or 0.01% of their United States portfolio. Alps Advisors owns 31,780 shares. We plan to provide a corporate update later this year. Renaissance Tech Llc reported 49,400 shares. Alps Advsr holds 0% of its portfolio in Versartis Inc (NASDAQ:VSAR) for 31,780 shares. Voya Invest Mgmt Limited Liability Corporation reported 14,960 shares stake.

Both of these companies are focused on GHD, and with Versartis going back to the drawing board, Ascendis might not have any real competition. New York-based Pfizer Inc., with Opko Health Inc., of Miami, has the LAGH somatrogon, also known as HGH-CTP (size: 48 kDa); a phase III trial missed the primary endpoint of change in trunk fat mass from baseline to 26 weeks vs. placebo in adult GHD, but a pediatric phase III is underway. Tfs Cap Limited Company accumulated 81,527 shares or 0.32% of the stock.

Comments